Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Pandemic H1N1 Influenza
Interventions: Biological: GSK Biologicals' investigational vaccine GSK2340273A (alternative formulations); Biological: GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010